School of Medicine
Showing 1-10 of 40 Results
-
Oxana Palesh
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) at the Stanford University Medical Center
Current Research and Scholarly Interests Research focused on developing interventions for management of side effects of cancer treatments (e.g., sleep disturbance, fatigue, depression, anxiety).
-
Heather Ryan Pankow
Life Science Research Professional 2, Psych/General Psychiatry and Psychology (Adult)
Bio Heather graduated with a BS in Microbiology with an emphasis in Biotechnology from Florida Atlantic University. She is a Life Science Research Professional that joined the Department of Psychiatry in 2000, exploring genetic markers in antidepressant treatment and smoking cessation, gene expression in Alzheimer’s disease transgenic mouse models, cytokine expression in primary microglia and microglial-hippocampal organotypic co-cultures, and organizing a database of mood disorders subjects across labs to facilitate collaboration. She recently shifted focus to clinical research and is excited to be involved with the human side of the DNA she has been studying. She is looking forward to contributing to the advance of treatment options for depression and other mood disorders.
-
Pablo Paredes Castro
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests PRECISE, PERSONALIZED & AFFORDABLE WELLBEING TECHNOLOGY
Combining medicine, design, and engineering principles, we research novel technologies to keep people healthy and productive. Our goal is to discover revolutionary ways of broadly delivering both universal and selective, preventive, and self-sustaining, daily life interventions. -
Karen J. Parker, PhD
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly Interests The Parker Lab conducts research on the biology of social functioning in monkeys, typically developing humans, and patients with social impairments.
